Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates

被引:21
作者
Kitamoto, S
Nakano, K
Hirouchi, Y
Kohjimoto, Y
Kitajima, S
Usui, M
Inoue, S
Egashira, K
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Higashi Ku, Fukuoka 8128582, Japan
[2] Primate LTD, Kumamoto, Japan
关键词
atherosclerosis; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors nonhuman primates; inflammation; regression;
D O I
10.1161/01.ATV.0000134518.27241.da
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Anti-atherosclerotic effects of statins might be mediated partly by pleiotropic cholesterol-lowering independent mechanisms. We used nonhuman primates and examined whether treatment with pravastatin or antimonocyte chemoattractant protein-1 (MCP-1) therapy can induce regression and stabilization of established atherosclerotic lesions through cholesterol-lowering independent mechanisms. Methods and Results-Advanced atherosclerosis was induced in the abdominal aorta and the common iliac artery of cynomolgus monkeys by undergoing balloon injury and giving atherogenic diet for 6 months. At 6 months, the diet was changed to normal chow, and the animals were allocated to 4 treatment groups: control vehicle group and other groups treated with pravastatin (1 or 10 mg/kg) or with mutant MCP-1 gene transfection for additional 6 months. Each compound was treated instead of the atherogenic diet, and cholesterol contents in pravastatin-treated groups were adjusted to equalize plasma cholesterol level among groups. Pravastatin reduced neointimal formation in the aorta, but not in the common iliac artery. Pravastatin reduced intimal macrophage area and other markers of plaque destabilization in the common iliac artery. Equivalent inhibitory effects were observed in animals that received mutant MCP-1 gene transfection. No serious side effects were noted by 2 therapeutic modalities. Conclusion-This study demonstrated cholesterol-lowering independent regression and stabilization of established atherosclerotic lesions by pravastatin and by anti-MCP-1 therapy in nonhuman primates. An anti-inflammatory mechanism may be involved in the beneficial effects of pravastatin.
引用
收藏
页码:1522 / 1528
页数:7
相关论文
共 23 条
[1]   Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma - A potential mechanism of lesion stabilization [J].
Aikawa, M ;
Rabkin, E ;
Okada, Y ;
Voglic, SJ ;
Clinton, SK ;
Brinckerhoff, CE ;
Sukhova, GK ;
Libby, P .
CIRCULATION, 1998, 97 (24) :2433-2444
[2]   REDUCTION IN SERUM-CHOLESTEROL WITH PRAVASTATIN IMPROVES ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA [J].
EGASHIRA, K ;
HIROOKA, Y ;
KAI, H ;
SUGIMACHI, M ;
SUZUKI, S ;
INOU, T ;
TAKESHITA, A .
CIRCULATION, 1994, 89 (06) :2519-2524
[3]   Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis [J].
Egashira, K ;
Koyanagi, M ;
Kitamoto, S ;
Ni, WH ;
Kataoka, C ;
Morishita, R ;
Kaneda, Y ;
Akiyama, C ;
Nishida, KI ;
Sueishi, K ;
Takeshita, A .
FASEB JOURNAL, 2000, 14 (13) :1974-1978
[4]   Molecular mechanisms mediating inflammation in vascular disease - Special reference to monocyte chemoattractant protein-1 [J].
Egashira, K .
HYPERTENSION, 2003, 41 (03) :834-841
[5]   Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys [J].
Egashira, K ;
Zhao, QW ;
Kataoka, C ;
Ohtani, K ;
Usui, M ;
Charo, IF ;
Nishida, K ;
Inoue, S ;
Katoh, M ;
Ichiki, T ;
Takeshita, A .
CIRCULATION RESEARCH, 2002, 90 (11) :1167-1172
[6]   Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease [J].
Egashira, K .
CIRCULATION JOURNAL, 2002, 66 (06) :529-533
[7]   Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice [J].
Inoue, S ;
Egashira, K ;
Ni, WH ;
Kitamoto, S ;
Usui, M ;
Otani, K ;
Ishibashi, M ;
Hiasa, K ;
Nishida, K ;
Takeshita, A .
CIRCULATION, 2002, 106 (21) :2700-2706
[8]   Dietary lipid lowering modifies plaque phenotype in rabbit atheroma after angioplasty - A potential role of tissue factor [J].
Jeanpierre, E ;
Le Tourneau, T ;
Six, I ;
Zawadzki, C ;
Van Belle, E ;
Ezekowitz, MD ;
Bordet, R ;
Susen, S ;
Jude, B ;
Corseaux, D .
CIRCULATION, 2003, 108 (14) :1740-1745
[9]   Current concepts of the pathogenesis of the acute coronary syndromes [J].
Libby, P .
CIRCULATION, 2001, 104 (03) :365-372
[10]   Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin) [J].
Masumoto, A ;
Hirooka, Y ;
Hironaga, K ;
Eshima, K ;
Setoguchi, S ;
Egashira, K ;
Takeshita, A .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (11) :1291-+